Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.69M Sell
59,789
-2,289
-4% -$316K 0.34% 53
2026
Q2
$7.98M Sell
62,078
-5,840
-9% -$684K 0.32% 60
2026
Q1
$8.17M Sell
67,918
-5,903
-8% -$681K 0.36% 47
2025
Q4
$7.77M Buy
73,821
+55,706
+308% +$5.23M 0.34% 59
2025
Q3
$1.52M Buy
18,115
+1,555
+9% +$128K 0.11% 165
2025
Q2
$1.31M Sell
16,560
-778
-4% -$61.8K 0.1% 182
2025
Q1
$1.56M Sell
17,338
-302
-2% -$28.2K 0.14% 148
2024
Q4
$1.75M Sell
17,640
-919
-5% -$94.7K 0.15% 124
2024
Q3
$2.11M Buy
+18,559
New +$2.2M 0.18% 105

Other funds holding MRK

BFC Planning's MRK Position: Q3 2026 in Review

BFC Planning reduced its Merck (MRK) stake by 3.7% in Q3 2026, selling an estimated $316K and leaving 59,789 shares worth $8.69M. The position accounts for 0.34% of the portfolio, ranked #53.

BFC Planning first reported a position in MRK in Q3 2024 and has held it in 9 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • BFC Planning held 59,789 shares of Merck worth $8.69M as of Q3 2026.
  • BFC Planning sold 2,289 Merck shares in Q3 2026, an estimated $316K.
  • Merck made up 0.34% of BFC Planning's portfolio in Q3 2026, its #53 holding.
  • BFC Planning first reported a position in Merck in Q3 2024 and has held it in 9 quarters since.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.